It has been generally accepted that DCM has similar pathological mechanisms in both type 1 and type 2 diabetes 50, but FGF21 has been demonstrated to have different changing patterns of serum level increase in type 2 diabetes and decrease in type 1 diabetes 37. This evidence concerns the gene FGF21 and type 1 diabetes mellitus.